companydata.dkcompanydata.dk

ResMed Denmark A/S: Financial statements 2020

CVR: 30699246

Source: annual report 2020, Danish Business Authority

01/07/2019 – 30/06/2020

ResMed Denmark A/S (CVR 30699246) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 13,913,907 and a net result of DKK 2,617,103 compared with DKK 1,124,288 the year before. That is an increase of 11.1% compared with the year before. Equity in the 2020 report amounted to DKK 15,444,193. The solvency ratio was 62.9%. The company had 16 employees in the financial year.

Gross Profit
DKK 13,913,907
Profit/Loss
DKK 2,617,103
Equity
DKK 15,444,193
Total Assets
DKK 24,548,408
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-13.9M2.6M15.4M16
2019-12.5M1.1M12.8M16
2018-16.5M3.9M11.7M18
2017-16.6M3.9M12.8M18
2014--00-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ResMed Denmark A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About ResMed Denmark A/S

ResMed Denmark A/S is a Danish company of the type Aktieselskab based in Maribo, founded in 2007. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ResMed Maribo A/S and MARIBO MEDICO A/S. The management consists of Malene Brun Petersen. The board consists of Michael James Rider (chair), Jussi Antero Vuorela, Malene Brun Petersen and Nigel Wayne Robinson. The company is owned by ResMed Sensor Technologies Ltd. The company has 22 employees (2026). In 2025, the company reported a gross profit of DKK 27,103,584 and a net result of DKK 7,641,198 compared with DKK 5,923,165 the year before. Equity in the 2025 report amounted to DKK 42,043,276.

Source: annual report 2025, Danish Business Authority